3-hydroxybutyric acid has been researched along with fenofibrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auvin, S; Bordet, R; Bouchaert, E; Lecointe, C; Porta, N; Staels, B; Vallée, L | 1 |
| Cui, GB; Liu, L; Liu, YH; Ma, B; Sun, JJ; Wu, ZM; Xu, QY; Yang, ZD; Yao, D; Zhang, Q | 1 |
2 other study(ies) available for 3-hydroxybutyric acid and fenofibrate
| Article | Year |
|---|---|
Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties.
Topics: 3-Hydroxybutyric Acid; Analysis of Variance; Animals; Body Weight; Diet, Ketogenic; Disease Models, Animal; Electroencephalography; Epilepsy; Fenofibrate; Hypolipidemic Agents; Ketone Bodies; Lithium Chloride; Liver; Male; Organ Size; Pentylenetetrazole; Pilocarpine; PPAR alpha; Rats; Rats, Wistar; Reaction Time | 2009 |
Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.
Topics: 3-Hydroxybutyric Acid; Animals; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diet, High-Fat; Fenofibrate; Hyperlipidemias; Isoleucine; Linoleic Acid; Male; Metabolome; Metabolomics; Ornithine; Rats; Rats, Sprague-Dawley; Simvastatin; Tyrosine | 2014 |